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Abstract
In mammals, corticotrophin-releasing hormone (CRH) and related peptides are known to play essential
roles in the regulation of neuroendocrine, autonomic and behavioural responses to physical and emotional
stress. In nonmammalian species, CRH-like peptides are hypothesized to play similar neuroendocrine and
neurocrine roles. However, there is relatively little detailed information on the distribution of CRH
neurones in the central nervous system (CNS) of nonmammalian vertebrates, and there are currently no
comparative data on stress-induced changes in CRH neuronal physiology. We used a specific, affinity-
purified antibody raised against synthetic Xenopus laevis CRH to map the distribution of CRH in the CNS of
juvenile South African clawed frogs. We then analysed stress-induced changes in CRH immunoreactivity
(CRH-ir) throughout the CNS. We found that CRH-positive cell bodies and fibres are widely distributed
throughout the brain and rostral spinal cord of juvenile X. laevis. Strong CRH-immunoreactovity (ir) was
found in cell bodies and fibres in the anterior preoptic area (POA, an area homologous to the mammalian
paraventricular nucleus) and the external zone of the median eminence. Specific CRH-ir cell bodies and
fibres were also identified in the septum, pallium and striatum in the telencephalon; the amygdala, bed
nucleus of the stria terminalis and various hypothalamic and thalamic nuclei in the diencephalon; the
tectum, torus semicircularis and tegmental nuclei of the mesencephalon; the cerebellum and locus
coeruleus in the rhombencephalon; and the ventral horn of the rostral spinal cord. To determine if exposure
to an acute physical stressor alters CRH neuronal physiology, we exposed juvenile frogs to shaking/handling
and conducted morphometric analysis. Plasma corticosterone was significantly elevated by 30 min after
exposure to the stressor and continued to increase up to 6 h. Morphometric analysis of CRH-ir after 4 h of
stress showed a significant increase in CRH-ir in parvocellular neurones of the anterior preoptic area, the
medial amygdala and the bed nucleus of the stria terminalis, but not in other brain regions. The stress-
induced increase in CRH-ir in the POA was associated with increased Fos-like immunoreactivity (Fos-LI), and
confocal microscopy showed that CRH-ir colocalized with Fos-LI in a subset of Fos-LI-positive neurones.
Our results support the view that the basic pattern of CNS CRH expression arose early in vertebrate
evolution and lend further support to earlier studies suggesting that amphibians may be a transitional
species for descending CRH-ergic pathways. Furthermore, CRH neurones in the frog brain exhibit
changes in response to a physical stressor that parallel those seen in mammals, and thus are likely to play an
active role in mediating neuroendocrine, behavioural and autonomic stress responses.
Corticotrophin-releasing hormone (CRH), a 41-amino acid
neuropeptide first isolated by Vale and colleagues from the
ovine hypothalamus (1), has since been isolated and charac-
terized in representatives of most vertebrate classes (2).
Subsequent to its isolation, it was discovered that CRH is a
member of a family of related peptides in vertebrates that
includes the fish urotensins-I, frog sauvagine and the urocor-
tin/stresscopin peptides (2). Corticotrophin-releasing hormone
is generally regarded as the primary hypothalamic neurohor-
mone within the hypothalamic-pituitary-adrenal (HPA) axis
responsible for mediating neuroendocrine responses to stress.
In addition to its role as a hypophysiotrophin, CRH also
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functions as a neurotransmitter/neuromodulator, media-
ting autonomic and behavioural responses to stress (2, 3).
However, these conclusions are based largely on studies in
mammals, with little comparative data available in nonmam-
malian species.
The mature CRH peptide is highly conserved among
vertebrates, especially among the tetrapods (2). There are two
closely related CRH genes in Xenopus laevis (designated
xCRHa and xCRHb) due to the pseudotetraploid nature of
its genome (4). The mature peptides encoded by the two genes
are identical in their deduced primary amino acid sequences.
The amino acid sequences of the CRHs from human and rat
are identical, and differ from the frog peptide in only three
positions (5, 6). Among the few amphibian species in which
CRH has been cloned, the mature peptides of Spea hammon-
dii (GenBank accession #AY262255) and Phyllomedusa
sauvageii (GenBank accession #AY596828) are identical to
X. laevis (GenBank accession #S50096), while the CRH of
Rana catesbeiana differs from the other anuran peptides in
only the first amino acid residue (GenBank accession
#AB161633).
In mammals, CRH is widely distributed throughout the
CNS, but a circumscribed group of parvocellular neurosecre-
tory neurones localized to the paraventricular nucleus of the
hypothalamus (PVN) comprise the major hypophysiotropic
neurones of the HPA axis. The PVN neurones are the
principal source of CRH delivered to the external zone of the
median eminence, where CRH is released into the hypophy-
seal portal system and subsequently stimulates the release of
adrenocorticotrophic hormone from the anterior pituitary (7,
8).
Earlier studies of the distribution of CRH-like immunore-
activity in amphibians depended on the use of antisera raised
against mammalian CRHs. CRH-immunoreactivity (ir) has
been shown in somata and fibres in the brain and pituitary of
several amphibian species: Urodela: Pleurodeles waltlii, Am-
bystoma mexicaum (9) and Triturus cristatus (10); Anura:
Rana ridibunda (9, 11), Rana catesbeiana (11) and X. laevis (9,
12). In these studies, the greatest intensity of CRH-like
immunoreactivity was found in the preoptic nucleus (homo-
logue of the mammalian PVN) and in the external zone of the
median eminence. Close morphological examination of CRH
projections in ranid frogs revealed that the CRH neurones of
the ventral preoptic nucleus project caudally and terminate in
the external zone of the median eminence (11, 13, 14).
Most studies in amphibians have focused on the hypo-
physiotropic CRH neurones and little attention has been
directed towards other CRH systems in the brain and spinal
cord. Using heterologous antisera Bhargava and Rao (15)
reported CRH-ir in the mesencephalon (optic tectum and
interpeduncular nucleus) of tiger frogs and Olivereau et al. (9)
reported CRH-ir in the cerebellum and interpeduncular
nucleus of two ranid and two urodele species. In rats, the
CRH neurones of the PVN (particularly the parvocellular
neurones) have been shown to be stress-responsive. For
example, CRH gene expression (mRNA, heteronuclear RNA
or CRH-ir) increased in the PVN following exposure to
different stressor paradigms (16–26). However, these neu-
rones respond differently to different kinds of stressors, and
decreases in CRH gene expression (mRNA or CRH-ir) in
these cells as well as no change have been reported (18, 27–
29). Similar studies have yet to be conducted in species other
than rats.
In the present study, we used homologous, affinity purified
antibodies generated against synthetic X. laevis CRH (xCRH)
to map the distribution of CRH-ir somata and fibres
throughout the CNS of juvenile X. laevis. We then used
morphometric analysis to analyse stress-induced changes in
CRH neuronal physiology throughout the frog brain. Our
results support and extend previous studies of CRH-ir in the
frog brain by showing, in addition to forebrain and mesen-
cephalic locations previously reported (9–12, 15, 30), strong
CRH expression in the cerebellum, rhombencephalon and
rostral spinal cord of frogs. We also present evidence for
stress-activation of CRH neurones in the anterior preoptic
area (POA), the medial amygdala (MeA), and the bed nucleus
of the stria terminalis (BNST) in X. laevis. We also show that
the immediate early gene product Fos (Fos-like immunore-
activity; Fos-LI) increased in the POA following exposure to
the stressor and Fos-LI was colocalized with CRH-ir in a
subset of Fos-LI-positive neurones.
Materials and methods
Animals and tissue preparation
Juvenile X. laevis (weighing 2.5–5.0 g) were derived from an inhouse breeding
stock (population originally derived from Xenopus I, Dexter, MI, USA).
Animals were fed beef liver and maintained at 22–23 C on a 12 : 12 h light/
dark cycle. For immunohistochemical mapping of CRH neurones and
processes, animals were anaesthetized by immersion in 0.01% benzocaine
and given intracerebroventricular injections of colchicine (7.5 ng/ll in 0.06%
saline and 1% methyl green, 150–200 nl/injection). Frogs were killed 42 h
after injection and the skulls were fixed overnight in 4% paraformaldehyde at
4 C.
The brains were dissected and postfixed for 1 h, followed by immersion in
30% sucrose/phosphate-buffered saline (PBS) at 4 C overnight. Following
the protection with sucrose, brains were snap-frozen and stored at )80 C
until sectioning. Before sectioning, brains were embedded using M-1 embed-
ding matrix (Shandon Lipshaw, Inc., Pittsburgh, PA, USA). Brains were
cryosectioned transversely at 12 lm and stored at )80 C until analysis. Eight
brains were analysed for CRH-ir distribution in the frog CNS.
Antibody purification
We identified CRH-positive neurones and processes using a polyclonal rabbit
antiserum raised against synthetic X. laevis CRH (xCRH) conjugated to
human alpha globulins (31, 32). The immunoglobilin (Ig)G fraction of the
xCRH antiserum was first affinity purified using an Affi-Gel Protein A
purification column and a column containing xCRH conjugated to Affi-Gel 10
(Bio-Rad Laboratories, CA, USA). The construction of the xCRH-Affi-Gel
10 matrix was modified to adjust for the low isoelectric point of xCRH
(pI ¼ 5.05) following the manufacturer’s specifications. The affinity column
was prepared by coupling 1 mg of synthetic xCRH dissolved in 1 ml coupling
buffer (0.1 M MOPS pH ¼ 7.5, 80 mM CaCl2) to 0.5 ml washed Affi-Gel 10
matrix. The reaction included 100 000 c.p.m. [125I]-xCRH (prepared by the
iodogen method) (31) to allow for determination of coupling efficiency (which
was 86%).
We recently isolated cDNA clones for X. laevis urocortin 1 (UCN1)
(GenBank accession #AY596827) and UCN3 (GenBank accession
#AY596826; G. C. Boorse and R. J. Denver, unpublished data) and have
synthesized the peptides based on their deduced amino acid sequences. The
deduced amino acid sequence of X. laevis UCN1 (xUCN1) is 72.5% similar to
rodent UCN1. Xenopus laevis UCN3 (xUCN3) shares 87.5% sequence
similarity with rodent UCN3. We determined the crossreactivities of our
xCRH antiserum with xUCN1 and xUCN3 by radioimmunoassay [for
crossreactivity analysis with heterologous CRH-like peptides, see (32)]. The
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xUCN1 showed approximately 3% crossreaction, while UCN3 did not
crossreact with the anti-xCRH serum (G. C. Boorse and R. J. Denver,
unpublished data). We used these peptides to preabsorb our anti-xCRH IgG
before immunohistochemistry (see below).
Immunohistochemistry
Immunohistochemistry was used to localize xCRH-ir and Fos-like immuno-
reactivity (Fos-LI) neurones in the brain and rostral spinal cord. The rabbit
polyclonal c-fos antiserum that we used (sc-253; Santa Cruz Biotechnology,
Santa Cruz, CA, USA) was raised against an epitope that shares 88%
sequence similarity with Xenopus c-fos (communication with Santa Cruz
Biotechnology; the sequence of the epitope is proprietary) and has been used
successfully for detection of Fos-LI in X. laevis (33). The specificity of our
affinity-purified anti-xCRH IgG was confirmed by preabsorption of the
primary antibody with synthetic xCRH, xUCN1 or xUCN3 (50 lg/ml)
overnight at 4 C before immunohistochemistry.
We used two methods to detect CRH-ir and Fos-LI, immunofluorescence
or horseradish peroxidase/diaminobenzidine (HRP/DAB). For immunofluo-
rescent detection, sections were incubated in the primary antiserum [1 : 15
dilution for the anti-xCRH IgG, and 1 : 4000 dilution for anti-Fos serum in
PBS with 2% normal goat serum (NGS)] for 20 h at 20 C or 4 C. For HRP/
DAB, tissue sections were first incubated in 0.3% hydrogen peroxide (in
distilled water) for 30 min to quench endogenous peroxidase activity, followed
by 30 min incubation in 2% NGS in PBS. We used a Vectastain elite ABC kit
(rabbit) and Vector VIP kit (both from Vector Laboratories, Inc., Burlingame,
CA, USA) for HRP/DAB staining following the manufacturer’s protocols.
The micrographs shown in the figures are derived from HRP/DAB staining
(except for the dual immunofluorescence data), but both methods provided
identical results with regard to the distribution of CRH-ir cells. However, the
immunofluorescence method allowed for better visualization of neuronal
processes, and thus CRH-ir fibres depicted in Figs 2 and 3 are based on
analysis by immunofluorescence.
Because antisera to both xCRH and c-fos were generated in rabbits, we
conducted dual immunofluorescence histochemistry according to the methods
of Negoescu et al. (34). This method depends on sequential incubation with
primary antisera and the use of a fluorescein (FITC)-conjugated Fab fragment
as the secondary antibody for the first primary antibody (in our case, the anti-
xCRH). Briefly, cryosections were incubated in blocking buffer (10% normal
goat serum in TBS) for 1 h at room temperature and then incubated overnight
at 4 C with the affinity purified anti-xCRH IgG diluted 1 : 15 in blocking
buffer. Sections were washed three times with TBS and then incubated
overnight at 4 C with a fluorescein (FITC)-conjugated Fab fragment of goat
anti-rabbit IgG (H + L) (diluted 1 : 100; Jackson ImmunoResearch, PA,
USA). After rinsing, the sections were incubated with the anti-Fos serum
(1 : 4000) for 3 h at room temperature, followed by extensive washes and then
incubation with a Cy3-conjugated polyconal goat anti-rabbit IgG (1 : 1000;
Jackson ImmunoResearch) for 2 h at room temperature. After rinsing, the
sections were nuclear-counterstained with DAPI (200 ng/ml; Sigma D9542;
Sigma, St Louis, MO, USA) for 30 min, then cover-slipped with Prolong
Anti-Fade (Molecular Probes, OR, USA). To control for crossreaction of the
second secondary antibody with the first primary antibody, we conducted
interference control staining for the use of Fab fragment as described by
Negoescu et al. (34). Briefly, the dual immunofluorescence procedures were
conducted by substitution of nonimmune serum for the second primary
antiserum (i.e. rabbit anti-Fos serum). No staining by the second secondary
antiserum (i.e. Cy3-conjugated goat anti-rabbit IgG) was observed, demon-
strating that the Fab fragment of goat anti-rabbit IgG saturated all the
immunoreactive sites of the first primary antibody (i.e. rabbit anti-xCRH
IgG), and no crossreaction occurred between the second secondary antiserum
and the first primary antibody. Single immunofluorescence histochemistry for
xCRH or c-fos was also conducted for comparison.
Routine fluorescence microscopy was conducted using an Olympus
U-TBI90 microscope and digital images captured using a Retiga 1300R
camera. Sections were also analysed by confocal microscopy (Zeiss laser
scanning confocalmicroscope). Optical sections (1 lmthickness) were captured
through the Z-axis to determine if CRH-ir and Fos-LI were colocalized.
Shaking stressor
Two days before the start of the experiment, juvenile frogs (weighing 5–8 g)
were randomly assigned to treatment groups and placed in tanks surrounded
by opaque barriers to block visual stimuli. On the day of the experiment, the
stressed group was placed into 32 oz white polypropylene containers, with
three frogs in 250 ml well water. The containers were placed on an orbital
shaker and shaken continuously at 100 r.p.m. for various times. The shaking
intensity was just enough to require constant spatial adjustment by the frogs
but not enough to cause physical damage (35). The frogs were killed by
submersion in 0.05% benzocaine. The unstressed (nonhandled) group was
killed at the same time. For plasma corticosterone analysis, frogs were killed
at 0, 30 min, 3 h and 6 h after the initiation of the shaking stressor (n ¼ 10/
time point). For immunohistochemistry, frogs were euthanized at 0 time and
then 4 h after the initiation of the shaking stressor (n ¼ 6/time point). All
frogs were weighed, blood was collected immediately into prechilled capillary
tubes, and heads were fixed in cold 4% paraformaldehyde.
Plasma corticosterone radioimmunoassay (RIA)
Corticosterone was measured in frog plasma using methods described by Licht
et al. (36). Briefly, plasma was extracted using diethyl ether and the RIA was
conducted using a corticosterone antiserum obtained from Esoterix Endocrin-
ology (San Diego, CA, USA). All samples were measured in a single assay, and
the intra-assay coefficient of variation was 10%. The effect of exposure to the
shaking stressor on plasma corticosterone content was analysed using one-way
analysis of variance of shaking time versus corticosterone content.
Morphometric analysis of CRH immunoreactivity
CRH immunoreactivity was quantified on brain sections using MetaMorph
software (version 6.2r4; Universal Imaging Corporation, Downingtown, PA,
USA). All sections were processed simultaneously under identical conditions.
Three to five sections containing each brain region of interest were analysed for
each animal. All sections were carefully matched for anatomical level, and
digital images were captured at · 100 or · 200 magnification for densitometric
analysis. A random procedure was carried out throughout the image analysis.
The brain regions were analysed using a hand-made frame covering the
complete area of interest, and the total area of the positive staining particles
above a standard density threshold in the selected area was counted
automatically. The mean density for each animal was calculated as the total
positive staining area on the multiple sections divided by the total selected area.
The effects of the shaking stressor on CRH-ir mean density in the brain regions
investigated were analysed by Student’s unpaired t-test (P < 0.05) using the
SPSS statistical package v11.5 for Windows (SPSS Inc., Chicago, IL, USA).
Results
Distribution of CRH immunoreactivity in juvenile X. laevis
brain and spinal cord
We found CRH-ir cell bodies and fibres to be widely
distributed throughout the CNS of juvenile X. laevis. Alter-
nating sections exhibited robust staining in the same neuroan-
atomical regions. Furthermore, preabsorption of the affinity-
purified antibodies with synthetic xCRH completely abolished
all staining, while preabsorption with synthetic xUCN1 or
xUCN3 did not alter staining, thus demonstrating the specif-
icity of the antibodies (Fig. 1). Well-organized groups of cells
and fibres were found in regions of the telencephalon,
diencephalon, mesencephalon, rhombencephalon and rostral
spinal cord. Contrary to earlier reports that used heterologous
antisera (13, 37), we did not observe CRH-ir in the pituitary
gland. A schematic representation of the distribution of CRH
positive cell bodies and fibres throughout the X. laevis brain
and rostral spinal cord is shown in Figs 2 and 3.
Telencephalon
The most rostral sites of CRH-ir were localized to small
somata in the mitral layer of the olfactory bulb, the medial
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septum, medial, dorsal and lateral pallium, and striatum.
Large somata with CRH-ir axons were found in the nucleus
accumbens and less frequently in the lateral pallium (Fig. 2A–
C; see also Fig. 4A–D).
Diencephalon
The largest group of CRH-ir cells was found in both the
magnocellular and parvocellular divisions of the POA
(Fig. 2D,E; see also Fig. 4F). Immunoreactive somata were
predominantly found in the subependymal zones with axons
projecting medially, sending projections towards the third
ventricle, and also laterally. Sparse but large immunoreactive
somata were seen in the ependymal zones with axons
projecting medially to the ventricle. In caudal regions of the
POA, immunoreactive somata were also found in a more
dorsal position with axons projecting ventrolaterally.
Scattered, smaller CRH-ir cells and fibres were locali-
zed to the amygdala and the bed nucleus of the stria
terminalis (Fig. 2D; see also Fig. 4E,G). Well-organized
groups of smaller cells were also observed in various
hypothalamic and thalamic nuclei (Fig. 2D–F, see also
Fig. 4H,I). In the thalamus, CRH-ir was observed in well-
organized bands of cells consistent with the neuroanatomical
organization and localization of the habenular, anterior
thalamic, ventromedial thalamic and ventrolateral thalamic
nuclei. The ventral thalamus and posterior tubercle contained
larger somata, localized to ventricular regions with axons
projecting ventrolaterally and dorsolaterally, respectively.
Strong immunoreactive fibre staining was present in the
external capsule of the median eminence (Fig. 3H; see also
Figs 1 and 5B). There was an absence of CRH-ir cells in all
pituitary lobes.
Mesencephalon
Relatively weak but specific staining of smaller cells was
observed in the oculomotor nuclei, tectal regions, the torus
(A) (B)
(C) (D)
Fig. 1. Photomicrographs of transverse sections through the brain of a juvenile Xenopus laevis at the level of the median eminence showing the specificity of the
affinity-purified anti-xCRH immunoglobulin (Ig)G. Dorsal is up in the photomicrographs in this and all other figures. Adjacent transverse sections were
incubated with affinity-purified anti-xCRH IgG (A) or with anti-xCRH IgG that had been preabsorbed with 50 lg/ml of synthetic xCRH (B), xUCN1 (C) or
xUCN3 (D). Scale bar ¼ 200 lm.
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semicircularis (homologue of the mammalian inferior colli-
culi), and various tegmental nuclei (Fig. 3H,I; see also
Fig. 5C,D).
Rhombencephalon
Robust CRH-ir was localized to the locus coeruleus (Fig. 3J;
see also Fig. 5E) and the cerebellum (primarily the Purkinje
cell layer, Fig. 3K; see also Fig. 5F). Smaller immunoreactive
cells were localized to the reticular nuclei, and the nuclei of
cranial nerves V (trigeminal motor), VIIId/v (nucleus of the
lateral line), IX (glossopharyngeal) and X (vagal) (Fig. 3K–M;
see also Fig. 5G).
Rostral spinal cord
CRH-ir was restricted to the ventral horn of the rostral spinal
cord. Robust staining was present in the large pyramidal-
shaped lateral motor neurones (Fig. 3N). Less intense CRH-ir
was observed in smaller cells of the medial and dorsal regions
of the ventral horn. Caudal regions of the spinal cord were
not examined.



















































Fig. 2. Schematic coronal illustration of corticotrophin-releasing hormone (CRH)-immunoreactivity (ir) distribution in forebrain regions of juvenile Xenopus
laevis. The drawing at the top of the figure shows a dorsal view of the whole brain. xCRH-ir in coronal sections (16 lm) of juvenile X. laevis brain. Letters
correspond to the rostro-caudal location of sections as depicted in the whole brain drawing. Large circles represent large, robust CRH-ir, small circles represent
smaller cells with less reactive CRH-ir, and lines represent CRH-ir fibres. Robust CRH-ir was observed in the lateral pallium (lp), striatum (Str), nucleus
accumbens (Acc), anterior preoptic area (POA) and ventral hypothalamus (VH). See Table 1 for a complete description of abbreviations. The anatomical
drawings are from Tuinhof et al. (86) with modification of basal ganglia subdivisions according to Marin et al. (64).
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Effects of shaking stressor on CRH-ir in the CNS
Exposure of juvenile frogs to shaking stress resulted in the
rapid activation of the hypothalamic-pituitary-interrenal
(HPI) axis as demonstrated by a 3.6-fold increase in plasma
corticosterone by 30 min and a 4.3-fold increase by 3 h
(Fig. 6); plasma corticosterone continued to increase by
20-fold up to 6 h.
We analysed an intermediate time point (4 h) for changes
in CRH-ir in the frog CNS. The shaking stressor produced a
robust increase in the intensity of CRH-ir staining and the
number of CRH-ir positive neurones in the POA (Fig. 7). In
stressed animals, greater intensity of CRH staining was
observed in both the ependymal and subependymal zones
compared to unstressed controls. Densitometric analysis
revealed that shaking stress significantly increased CRH-ir
count density in the POA (ependymal and subependymal
zones analysed together; 177% of control, n ¼ 6/treatment,
P ¼ 0.0001) (Fig. 7). Exposure to the shaking stressor also
significantly increased CRH-ir in the MeA (134% of control,
n ¼ 5–6/treatment, P ¼ 0.028) and in the BNST (151% of
control, n ¼ 5–6/treatment, P ¼ 0.003) at the level of POA
(Fig. 7).
The shaking stressor did not alter CRH-ir in the median
eminence (n ¼ 5/treatment, P ¼ 0.8238). No changes in
CRH-ir were observed in the nucleus accumbens (n ¼ 5/
treatment, P ¼ 0.235), the locus ceoruleus (LC) (n ¼ 5–6/
treatment, P ¼ 0.365), or the cerebellum (n ¼ 5–6/treatment,
P ¼ 0.168).
Effects of shaking stress on Fos-LI
As previously described by Ubink et al. (33), we found Fos-
LI to be exclusively nuclear with varying intensity from cell to
cell. In the CNS of unstressed frogs, Fos-LI positive nuclei
were occasionally observed in the internal granule cell layer,
striatum, nucleus accumbens, lateral pallium and ventral
hypothalamic nucleus. No Fos-LI positive neurones were
seen in the POA in unstressed frogs, nor were they detected in
other regions of the hypothalamus, amygdala, BNST, thal-
amus, pituitary, optic tectum, cerebellum or spinal cord.
Following exposure to 4 h of shaking stressor, we observed
an increase in Fos-LI positive cells throughout the brain. In
addition to more Fos-LI-positive cells in the same regions as
in the unstressed frog brains, detectable Fos-LI expanded to
the lateral septum, medial pallium, lateral and medial
amygdala, BNST, POA, various thalamic nuclei, suprachias-
matic nucleus, posterior tuberculum, optic tectum, torus
semicircularis and tegmental nuclei. By contrast, we observed
no Fos-LI-positive cells in the cerebellum or the LC following
exposure to the shaking stressor. We quantified the robust
increase in the number of Fos-LI positive cells in the POA,
which were mainly localized to the rostro-ventral region
(n ¼ 5–6/treatment, P ¼ 0.002; Fig. 8). The total number of
Fos-LI-positive cells in the POA differed significantly between
individuals, ranging from 14 to 150 per animal.
Dual immunofluorescent, confocal microscopy for CRH
and Fos in the POA showed that these two proteins were
colocalized in a subset of Fos-LI-positive neurones (Fig. 9).
However, not all CRH-positive cells exhibited Fos-LI. We
were unable to quantify the numbers of Fos-LI, CRH-ir
and CRH-ir + Fos-LI positive cells precisely in this
experiment.
Discussion
We have mapped the distribution of CRH-positive somata
and fibres in the brain and rostral spinal cord of X. laevis
using a homologous and highly specific affinity-purified
antiserum. For the first time, we also show stressor-induced
changes in the physiology of discrete populations of CRH
neurones in the CNS of a nonmammalian species. The
Table 1. Abbreviations.
Abbreviation Definition
A Anterior thalamic nucleus
Acc Nucleus accumbens
BNST Bed nucleus of the stria terminalis
Cb Cerebellum
DB Nucleus of the diagonal band of Broca
dp Dorsal pallium
Hd Dorsal habenular nucleus
Hv Ventral habenular nucleus




La Lateral thalamic nucleus, pars anterior
LA Lateral amygdala
LC Locus coeruleus
lmf Lateral motor field of spinal grey
lp Lateral pallium








NPv Nucleus of the paraventricular organ



















VH Ventral hypothalamic nucleus
VLs Superficial ventral nucleus
VM Ventromedial thalamic nucleus
Vm Nucleus motorius nervi trigemini
Vpr Nucleus sensorius principalis nervi trigemini
IXm Nucleus motorius nervi glossopharyngei
Xm Nucleus motorius nervi vagi
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distribution of CRH-ir within the hypothalamus of X. laevis
reported here is in principal agreement with the distribution
of CRH-ir described in other amphibian species in which
antisera to mammalian CRHs were used (9, 11, 14, 15, 30).
Our findings of abundant CRH somata in the POA and
CRH-ir in the external zone of the ME and the existence of
fibres projecting from the POA to the ME are consistent with
previous studies and further support a role for CRH as a
hypophysiotrophin in amphibians. The absence of CRH-ir
cells in all pituitary lobes in our study is consistent with
previous findings in other amphibian species [Rana tigrina

















































Fig. 3. Schematic coronal illustration of corticotrophin-releasing hormone (CRH)-immunoreactivity (ir) distribution in hindbrain and rostral spinal cord
regions of juvenile Xenopus laevis. The drawing at the top of the figure shows a dorsal view of the whole brain. Letters correspond to the rostro-caudal location
of sections as depicted in the whole brain drawing. Large circles represent large, robust CRH-ir, small circles represent smaller cells with less reactive xCRH-ir,
and lines represent CRH-ir fibres. Robust CRH-ir was observed in the ventral thalamus (VH), posterior tuberacle (TP), median eminence (ME), cerebellum
(Cb), locus coeruleus (LC) and lateral motor neurones of the spinal cord, lmn. See Table 1 for a complete description of abbreviations.
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reports in X. laevis in which heterologous antisera were used
(13, 37). However, recent data suggest that the majority of
CRH-like immunoreactivity in the X. laevis pituitary neural
lobe is derived from UCN1 (M. Calle, L. Wang, G. J. H.
Corstens, T. Kozicz, R. J. Denver, H. P. Barendregt and
E. W. Roubos, unpublished data).
Few studies have examined the CRH-ir in locations outside
of the hypothalamic/pituitary region in amphibians in detail.
Our data provide the first detailed distribution map of CRH-
ir in the telecephalon, diencephalon, mesencephalon, rhomb-
encephalon and rostral spinal cord in an amphibian species.
The distribution of CRH-ir in the telecephalon of X. laevis is
consistent with previous results obtained in Rana tigrina and
Rana ridibunda (13, 15). We also identified CRH-ir positive
cells and fibres in the amygdala, which is in agreement with
previous reports in frogs (11, 15), reptiles (38–40), birds (41,
42) and mammals (43). In the mesencephalon of other
amphibian species, CRH-ir was reportedly restricted to the
interpeduncular nucleus and tectal regions (9, 15). By
contrast, in X. laevis, we observed expanded mesencephalic
sites of CRH-ir, including the oculomotor nuclei, tectal
regions, the torus semicirculus (homologue of the mammalian
inferior colliculi) and various tegmental nuclei. Consistent
with our study, the oculomotor complex has been shown to
express CRH-ir in reptiles (38, 40) and birds (44) while, in an

























Fig. 4. Photomicrographs of transverse sections through the forebrain and part of the midbrain of juvenile Xenopus laevis showing the distribution of
corticotrophin-releasing hormone (CRH)-immunoreactive (ir) somata and fibres. (A) Mitral layer of the olfactory bulb (ml). (B) Pallium. (C) Nucleus
accumbens (Acc). (D) Medial septum (ms). (E) Medial amygdala (MeA). (F) Anterior preoptic area (POA). (G) Bed nucleus of the stria terminalis (BNST). (H)
Anterior thalamic nucleus (A). (I) Suprachiasmatic nucleus (SC). See Table 1 for a complete description of abbreviations. Scale bars ¼ 75 lm. V, ventricle.
Central distribution and stress activation of CRH neurones in Xenopus 887
 2004 Blackwell Publishing Ltd, Journal of Neuroendocrinology, 16, 880–893
UCN-like-ir [Rana esculenta (45); using a heterologous
antiserum]. In the rhombencephalon, we identified robust
CRH-ir in the locus coeruleus and the cerebellum (primarily
the Purkinje cell layer). Although this pattern of CRH-ir has
not been described in other amphibian species, CRH is widely
expressed in the cerebellum (all three layers) and in the locus
coeruleus in mammals (41, 46, 47). In support of our findings
in X. laevis, the torus semicirculus and tectal regions are also
regions of CRH-ir in other vertebrates [reptiles (39); birds
(41); mammals (48)]. Reticular locations and cranial nerves
have not previously been shown to be CRH immunoreactive
in amphibian species; however, a number of other vertebrate
species including reptiles (38, 40) birds (41, 44, 49) and
mammals (43, 46, 47) exhibit CRH-ir in these areas. Ours is
the first study to report CRH-ir in the spinal cord of
amphibians. It should be noted that it is not clear whether
previous studies in amphibians investigated rostral spinal
cord levels for CRH-ir. Spinal cord CRH-ir has been
described in mammals; but, unlike frogs, it was localized to
the dorsal horn (48).
The wide distribution of CRH in the frog CNS is similar to
that reported inmammals, and further supports a role forCRH
as a neurotransmitter/neuromodulator in addition to its role as
a neurohormone.The existence ofCRH-ir in the subependymal
zones of the telecephalon, in the amygdala, the cerebellum,
locus coeruleus, various cranial nerve nuclei, and the spinal
cord in both mammals (43, 47, 50) and the frog, suggests that














Fig. 5. Photomicrographs of transverse sections through part of the midbrain and the hindbrain of juvenile Xenopus laevis showing the distribution of
corticotrophin-releasing hormone (CRH)-immunoreactive (ir) somata and fibres. (A) Ventral hypothalamic nucleus (VH). (B) Medium eminence (ME). (C)
Tegmental nuclei (Tn). (D) Optic tectum (tect). (E) Locus coeruleus (LC). (F) Cerebellum (Cb). (G) Motor nucleus of the trigeminal nerve (Vm). See Table 1 for
a complete description of abbreviations. Scale bars ¼ 75 lm. V, ventricle.
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circuitry arose early in vertebrate evolution; see also (2).
Furthermore, our study describes for the first time the presence
of descending CRH-ergic pathways in a nonamniote species.
Lovejoy and Balment (2) suggested that amphibians could
represent a transitional species with respect to descending
CRH-ergic pathways, and our results lend support to this idea.
It is now well established that the mammalian PVN
(homologous to the amphibian POA) is the principal site of
neuroendocrine responses to stress (51). Early studies in an
amphibian (Bufo melanosticus) found an elevation in plasma
corticosteroids after electrical stimulation of the POA, ventral
hypothalamus, or the median eminence, but not after
stimulation of other brain regions (52). Furthermore, lesion-
ing of the ventral region of the POA in X. laevis tadpoles
caused the pituitary corticotropes to regress (53). In the
present study, we investigated the effects of a physical
stressor, handling/shaking on CRH neuronal physiology in
X. laevis. Exposure to the shaking stressor for 4 h caused a
robust increase in both the CRH-ir staining intensity and the
number of cells stained in the POA compared to unstressed
controls (Fig. 5). We also observed significant increases in
CRH-ir in the MeA and BNST, which suggests that these
structures are involved in mediating the stress response. By
contrast, we found no changes in CRH-ir in the median
eminence, nucleus accumbens, locus coeruleus or cerebellum.
The robust increase in CRH-ir in the POA and the parallel
elevation of plasma corticosterone supports the view that
these are the primary hypophysiotropic CRH neurones
regulating the activity of the HPI axis in X. laevis.
Our findings that CRH-ir was increased in the MeA and in
the BNST at the level of POA in frogs represents the first
report that CRH neurones resident in these CNS structures
are responsive to stress. Studies of neuronal connections of
the amygdala in mammals reveal extensive connections with
cortical and subcortical regions; for a review, see (54, 55).
Electrical stimulation of the amygdala of rats elicited auto-
nomic, endocrine and behavioural responses similar to those
induced by exposure to stressors (56–58). In mammals, the
central nucleus of the amygdala (CeA) is involved with fear/
anxiety-related behaviours, and the MeA has been shown to
play a role in cardiovascular responses to restraint stress and
the control of haemodynamics (56, 57, 59–61). The BNST is
believed to play an important role in stress regulation of the
HPA axis by relaying to the PVN from the amygdala and the
hippocampus (62, 63).
The functions of the different compartments of the
amygdala and the BNST in nonmammalian species are
poorly understood. We followed the anatomical definition
of these nuclei suggested by Marin et al. (64) for the frog.
Among the compartments of the amygdaloid complex in
X. laevis, the CeA was not easily identified in our analyses.
Thus, the MeA region that we analysed could include a small
portion of the dorsal CeA because there is no anatomical
marker to clearly separate the two parts. Nonetheless, our
results clearly show that the MeA and the BNST are involved
in stress-circuitry in the amphibian CNS as in mammals,
suggesting that their stress-related functions were established
before the divergence of the amphibian and amniote lineages.
A critical component of the integrated physiological
response to a variety of stressors is the locus coeruleus-
noradrenaline (LC-NA)/autonomic nervous system located in
the brainstem (65, 66). The LC-NA/autonomic system
activates the mesocortical and mesolimbic dopaminergic
system, as well as the amygdala/hippocampal complex during
stress (59, 67–69). Furthermore, activation of the LC can
increase hypothalamic CRH secretion (70–74). CRH has been
proposed to function as a neurotransmitter to initiate
autonomic and behavioural responses via activation of the
LC-NA system during stress (8, 75). We identified CRH-ir in
the hindbrain in X. laevis, but we did not observe changes in
CRH-ir in the LC or in the cerebellum following exposure to
the shaking stressor. It is possible that we missed earlier or
later changes in CRH-ir in these regions because we examined
only a single time point in the current study. It is also possible
that other types of stressor not analysed in our study might
preferentially activate hindbrain CRH neurones. For exam-
ple, Boorse and Denver (76) found that exposure of Western
spadefoot toad tadpoles to simulated pond drying increased
hindbrain CRH content (as measured by tissue extraction and
RIA). Further study is required to reveal the role that extra-
hypothalamic CRH neurones play in stress responses in
amphibians.
The immediate early gene c-fos has been widely used as a
maker of neuronal activation, especially of stress-response
circuitry (77, 78). Studies in rodents show that c-fos mRNA
and/or Fos-ir is increased in stress-related structures in the
brain in response to a variety of stressors. For example, c-fos
mRNA expression was increased in the MeA and lateral
septum following exposure to two acute stressors (immobil-
ization and electrical foot-shock), in the MeA, lateral septum
and the suprachiasmatic nucleus following exposure to a
novel stressor (open field), and was induced in the CeA and
the lateral nucleus of the BNST by a systemic stressor (i.e.
injection of cytokines) (78–81). Our observation that Fos-LI
appeared in the MeA, BNST, lateral septum and suprachi-
asmatic nucleus following exposure to 4 h of shaking stressor
is in agreement with these data, suggesting that much of the



























Fig. 6. Plasma corticosterone concentrations of Xenopus laevis juveniles ex-
posed to shaking stress for various times (n ¼ 10/time point). Data pre-
sented are the mean ± SEM. Significant differences from unstressed
controls are denoted (*P < 0.05 and **P < 0.01).
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that is invariably activated by stress in rodents is the PVN. In
accordance with these data, our results show that the number
of Fos-LI-positive cells is elevated in the POA in the frog
X. laevis following exposure to shaking stress.
The robust increase in Fos-LI and its colocalization with
CRH-ir in the frog POA, similar to that observed in the
mammalian PVN (82, 83), suggests that the induction of Fos
and CRH by stress are functionally linked. For example, both
mammalian and frog CRH genes possess AP-1 sites to which
Fos-Jun heterodimers can bind (84), and there is evidence that
Fos can regulate CRH gene expression in rodents (27, 83, 85).
In conclusion, our findings in the frog X. laevis show that
the basic pattern of CRH expression in the CNS arose early in
vertebrate evolution. Our data also lend further support to
earlier studies suggesting that amphibians may be a trans-
itional species for descending CRH-ergic pathways. We found
that CRH neurones in the frog brain exhibit changes in
response to physical stress that parallel those seen in
mammals, and thus are likely to play important roles in the
mediation of neuroendocrine, behavioural and autonomic
responses to stress. Stressor activation of the POA, MeA and














































































Fig. 7. Effects of shaking stress on corticotrophin-releasing hormone (CRH)-immunoreactivity (ir) in the anterior preoptic area (POA), medial amygdala
(MeA) and bed nucleus of the stria terminalis (BNST) of juvenile Xenopus laevis. Micrographs are of representative transverse sections (12 lm) in the same
anatomical plane of the POA. Representative sections of unstressed animal brain are shown on the left, and those of stressed brain are shown on the right.
Scale bar ¼ 150 lm in the micrographs of the POA, and 75 lm in the micrographs of theMeA and BNST. The graphs show densitometric analyses of CRH-ir
in the POA, MeA and BNST of juvenile X. laevis following exposure to 4 h of shaking stress. CRH-ir mean density was significantly increased in the POA,
MeA and BNST in stressed X. laevis compared to unstressed controls. Data presented are the mean ± SEM. Significant differences from unstressed control
are denoted (*P < 0.05 and **P < 0.01).
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these CNS structures were established before the divergence
of the amphibian and amniote lineages.
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